18 March 2023
Impact Healthcare REIT
plc
(the
"Company")
BOARD
CHANGES
Impact Healthcare REIT plc (ticker:
IHR), the real estate investment trust which gives investors
exposure to a diversified portfolio of UK healthcare real estate
assets, in particular care homes, is pleased to announce that Cedi
Frederick will join the Board as an independent Non-Executive
Director on 1 April 2024.
Over his 40-year career, Cedi has held a number of senior management,
chief executive and board member positions in the healthcare and
housing sectors across the public, private and not-for-profit
arenas. He is currently Chair of NHS Kent and Medway, Chair
of the Health and Europe Centre, Co-Chair of Inspire for Black
Londoners, and Non-Executive Director of Sage Homes. Cedi is also
owner and Managing Director of Article Consulting Ltd, which works
with and supports the 'Leaders of Today and Tomorrow', and the CEO
of a health tech start-up. Previously, Cedi was a Non-Executive
Director of two specialist NHS Mental Health Trusts, Chair of an
NHS Hospital Trust and Governor of Canterbury Christ Church
University.
Cedi will also become a member of
the Audit, Nomination, Remuneration and Management Engagement
Committees on appointment.
Philip Hall has announced his
intention to retire as a Non-Executive Director at the Company's
AGM on 21 May 2024. Phil has been an invaluable colleague and
Director since our IPO in 2017. The Board and Investment
Manager would like to thank Philip for his great support and
contribution to the Company over the last seven
years.
Simon Laffin, Chair, commented:
"I am delighted to welcome Cedi
Frederick to the Board. We have been looking to strengthen further
the Board's experience in the broader healthcare arena, and Cedi's
extensive career in this sector and his wider expertise equip him
well to make a strong contribution to the Board. We very much
look forward to working with him. I would like to add my personal
thanks to Phil Hall, who has made a major contribution to the
success of the Company over the last seven years."
In accordance with the Listing
Rules, there are no further matters
required to be disclosed pursuant to LR9.6.13R in respect of Cedi
Frederick's appointment.
FOR
FURTHER INFORMATION, PLEASE CONTACT:
Impact Health Partners LLP
|
|
Via H/Advisors Maitland
|
Andrew Cowley
|
|
|
David Yaldron
|
|
|
|
|
|
|
|
|
Jefferies International Limited
|
|
020 7029 8000
|
Tom Yeadon
|
tyeadon@jefferies.com
|
|
Neil Winward
|
nwinward@jefferies.com
|
|
Ollie Nott
|
onott@jefferies.com
|
|
|
|
|
|
|
|
Winterflood Securities Limited
|
|
020 3100 0000
|
Neil Langford
|
neil.langford@winterflood.com
|
|
Joe Winkley
|
joe.winkley@winterflood.com
|
|
|
|
|
|
|
|
H/Advisors Maitland (Communications advisor)
|
impacthealth-maitland@h-advisors.global
|
|
James Benjamin
|
|
07747 113 930
|
Rachel Cohen
|
|
020 7379 5151
|
Billy Moran
|
|
020 7379 5151
|
The Company's LEI is
213800AX3FHPMJL4IJ53.
Further information on Impact
Healthcare REIT plc is available at www.impactreit.uk.
NOTES:
Impact Healthcare REIT plc acquires,
renovates, extends and redevelops high quality healthcare real
estate assets in the UK and lets these assets on long-term full
repairing and insuring leases to high-quality established healthcare operators which offer good
quality care, under leases which provide
the Company with attractive levels of rent
cover.
The Company aims to provide
shareholders with an attractive sustainable return, principally in
the form of quarterly income distributions and with the potential
for capital and income growth, through exposure to a diversified
and resilient portfolio of UK healthcare real estate assets, in
particular care homes for the elderly.
The Company's dividend policy is to
maintain a progressive dividend that is covered by adjusted
earnings.
On this basis, the target total
dividend for the year ending 31 December
2024 is 6.95 pence per share*, a 0.18 pence increase over
the 6.77 pence in dividends paid or declared per ordinary share for
the year ended 31 December 2023.
The Group's Ordinary Shares trade on
the main market of the London Stock Exchange, premium segment. The
Company is a constituent of the FTSE EPRA/NAREIT index.
* This is a
target only and not a profit forecast. There can be no assurance
that the target will be met and it should not be taken as an
indicator of the Company's expected or actual results.